Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
CRML$7.74-0.05(-0.71%)SAGA Metals Positions Wolverine Heavy REE Project Alongside Strange Lake and Tanbreez in Geological Peer Comparison SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTcCQX: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral ...[10:15:00 AM ET]PHRRF$0.04+0.00(+2.70%)PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157[10:01:00 AM ET]SMX$1.80+0.01(+0.84%)TechCrunch Feature on SMX Latest in Media Coverage of Company's Growing Global Profile and Technology[10:00:00 AM ET]ROK$446.86+3.05(+0.69%)Rockwell Automation Introduces SecureOT Capabilities to Help OEMs Address Emerging Cybersecurity Regulations Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced new ...[10:00:00 AM ET]APPN$50.23-1.73(-3.33%)Appian Announces 2026 US Public Sector Partner Award Winners Appian (Nasdaq: APPN) today announced the winners of its 2026 US Public Sector Partner Awards at Appian Government. The annual awards recognize...[10:00:00 AM ET]ETOLF$1.32+0.05(+3.78%)Check Point Secures AI-Scale Traffic for Neoclouds, Sovereign AI and the Enterprise with New Maestro Hyperscale Orchestrator[10:00:00 AM ET]EDGM$0.00-0.00(-33.33%)EdgeMode Answers the Call for Ready-to-Build Data Center Infrastructure to Shorten Lead Times[10:00:00 AM ET]

TRAX · NASDAQ

First Tracks Biotherapeutics Inc

$46.52 +0.76 (+1.67%)

Company overview

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$1.7B
Employees
104
Headquarters
San Diego, CA
Website
firsttracksbio.com
CEO
Daniel R. Faga
Listed
April 20, 2026
P/E
0.00
Dividend yield
0.00%

Company financials

Total assets
$291M
Total debt
$0.00

Price chart

13.3122.8132.3241.8251.32
TRAX 1D NASDAQ O44.80H46.28L44.79C45.76+0.38 (+0.83%)Vol170.75K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
TRAXFirst Tracks Biotherapeutics Inc Press release First Tracks Biotherapeutics Announces $200 Million Private Placement GlobeNewswire
TRAXFirst Tracks Biotherapeutics Inc Stock news First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor Seeking Alpha
TRAXFirst Tracks Biotherapeutics Inc Stock news First Tracks' ANB033 Clears Key Phase Ib Celiac Disease Study Goals MarketBeat
TRAXFirst Tracks Biotherapeutics Inc Stock news First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday Benzinga
TRAXFirst Tracks Biotherapeutics Inc Press release First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease GlobeNewswire
TRAXFirst Tracks Biotherapeutics Inc Press release First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026 GlobeNewswire
TRAXFirst Tracks Biotherapeutics Inc Stock news This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga
TRAXFirst Tracks Biotherapeutics Inc Stock news Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday Benzinga
TRAXFirst Tracks Biotherapeutics Inc Press release First Tracks Biotherapeutics Announces Participation in September Investor Conferences GlobeNewsWire
TRAXFirst Tracks Biotherapeutics Inc Stock news First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results Benzinga
TRAXFirst Tracks Biotherapeutics Inc Stock news Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday Benzinga
TRAXFirst Tracks Biotherapeutics Inc Press release First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update GlobeNewsWire
TRAXFirst Tracks Biotherapeutics Inc Stock news First Tracks Biotherapeutics (NASDAQ:TRAX) Receives Consensus Rating of “Moderate Buy” from Analysts Defense World
See more
FAQ

Questions about First Tracks Biotherapeutics Inc

What does First Tracks Biotherapeutics Inc do?
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
What is TRAX's market cap?
First Tracks Biotherapeutics Inc (TRAX) is a listed stock with a live quote. The latest market cap on this page is $1.7B.
Where is First Tracks Biotherapeutics Inc headquartered?
First Tracks Biotherapeutics Inc is headquartered in San Diego, CA.
How do I get TRAX news from the API?
Call GET /v1/news?tickers=TRAX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does TRAX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TRAX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the TRAX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs